Oct 2018

DESPERATE MOTHER STRUGGLES TO GET ACCESS TO CANNABIS FOR HER CHRONICALLY ILL CHILD

Despite medicinal cannabis being decriminalized across the country, due to uneven legislation across states governing the prescription and use of medical cannabis, it remains difficult to source. Alice, mother of four-year old Rhys who was born with a debilitating chromosome disorder, tells her story of how she, like many other mothers and patients, is risking fines or even jail to buy cannabis to treat the symptoms of her son’s condition. Read the article here.

One of ANTG’s proprietary medicinal cannabis strains, EVE Cannabis Indica, has been listed on the Australian Register of Therapeutic Goods (ARTG). The ARTG is a reference of therapeutic goods that can lawfully be supplied in or exported from Australia.

READ MORE >

In conjunction with the HMRI and lead biomedical scientist Dr Matt Dun, we’re investigating the anticancer properties of our plant varieties. Dr Matt Dun shares his initial thoughts on the joint research project.

READ MORE >

What’s most important in business – purpose or profit? At ANTG we get to achieve both.

READ MORE >

We are focused on research and development, partnering with leading scientists and medical institutions to develop cannabinoid medicines that offer safe and effective therapeutic benefits.

LEARN ABOUT ANTG HERE >